Top 5 Takeaways Prevalence and Demographics: Monkeypox virus (MPXV) infections in children and adolescents aged <18 years constituted only 0.3% of all U.S. cases during the study period, with no

Top 5 Takeaways: Safety Profile Similar to Monovalent Boosters: Early safety findings for bivalent COVID-19 mRNA booster doses in persons aged ≥12 years are consistent with those reported for monovalent

Top 5 Takeaways 1. 26,384 monkeypox cases were reported in the U.S. from May 17 to October 6, 2022, with a peak in mid-to-late August. 2. Disproportionate impact on Black

Top 5 Takeaways Outbreak of Sudan ebolavirus in Uganda: From September 18 to October 31, 2022, Uganda experienced its fifth outbreak of Ebola Virus Disease (EVD) caused by Sudan ebolavirus,

Top 5 Takeaways Bivalent Booster Recommendation: In fall 2022, the CDC recommended a bivalent mRNA COVID-19 vaccine booster dose for individuals aged 5 years and older, to be administered at

Top 5 Takeaways Significant Reduction in Human Cases: Human dracunculiasis (Guinea worm disease) cases decreased to 15 in 2021 and three in the first half of 2022, continuing the decline

Top 5 Takeaways Increased Hospitalization Rates: During the Omicron variant-predominant periods, hospitalization rates among infants aged <6 months increased compared to the Delta variant period, but severe disease indicators among

Top 5 Takeaways Perception vs Reality: Half of the surveyed adults in Michigan and Illinois who had recent SARS-CoV-2 infections perceived local COVID-19 transmission as low or moderate, despite high